Confluence Discovery Technologies, Inc.

Confluence Discovery Technologies (CDT), an Aclaris Therapeutics company, is a full service drug discovery contract research organization (CRO).

Confluence^® delivers custom solutions in biochemistry, enzymology, cell & molecular biology, immunology, in vivo biology, biomarker development, PK / PD relationships, computational & medicinal chemistry, and drug development / CMC.

We specialize in complex biological systems, drug-target interactions, immunology models, and preclinical and clinical biomarker development.